GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xintela AB (OSTO:XINT) » Definitions » Unearned Premiums

Xintela AB (OSTO:XINT) Unearned Premiums


View and export this data going back to 2016. Start your Free Trial

What is Xintela AB Unearned Premiums?

Unearned Premiums only applies to insurance companies.


Xintela AB (OSTO:XINT) Business Description

Traded in Other Exchanges
N/A
Address
Medicon Village, Lund, SWE, 22381
Xintela AB is a biomedical company which utilises its proprietary marker technology XINMARK to develop stem cell-based therapies (XSTEM) for osteoarthritis and antibody-based therapies for Glioblastoma and Tripple-negative breast cancer. XSTEM is also evaluated for the treatment of the severe and deadly lung complication ARDS, which may affect covid-19 patients.